Belief BioMed Inc.

Belief BioMed Inc.

Private
ShanghaiHealthcare & Life Scienceshttps://www.beliefbiomed.com

Last Round

Series B

Mar 1, 2022

Total Funding Raised

$240.45M

Company Overview

Belief BioMed Inc. is a biotechnology company that develops, manufactures, and commercializes adeno-associated virus (AAV) based gene therapies for genetic and chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

gene therapyAAV gene therapyhemophilia gene therapycontract development and manufacturing organizationCDMOAAV vectorAAV manufacturingone-time gene therapyrare disease therapyhemophilia BGMP manufacturingbiotechDuchenne muscular dystrophyAAV capsid developmentParkinson's disease

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Belief BioMed Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Belief BioMed Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series BMar 1, 2022
Series BDec 1, 2020
Series AFeb 1, 2020
AngelJun 19, 2018

Key People

Founding team and executive leadership

Jane Zheng

Co-founder CEO

Founding Team

Vivian Ni

CEO EA PR AD

Executive Team

Belief BioMed Inc. Investors

Notable investors and investment history

InvestorRounds
MatrixSeries B
Northern Light Venture CapitalSeries A
Cenova CapitalSeries B
MPCiSeries B
CDG CapitalSeries B
Sherpa Healthcare PartnersSeries B, Series A
Lilly Asia VenturesSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 27, 2026

    Signed agreement for hemophilia A gene therapy in Greater China.

  • Mar 27, 2026

    Exclusive agreement with Grand Life Sciences Group for Greater China.

Belief BioMed Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Belief BioMed Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Belief BioMed Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range20
Year Founded2018
Last FundingMar 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.